Assessment of Psychosocial Distress in Cancer Patients and its Association with Quality of Life -A Cross-Sectional Study

Authors

  • PARVATHI SUDHA HARI Government Medical College Thiruvananthapuram, Kerala, India
  • Ciniraj Raveendran Government Medical College Thiruvananthapuram, Kerala, India
  • Sudha Padmam Regional Cancer Center, Thiruvananthapuram , Kerala , India
  • Libu G K Government Medical College, Kollam, Kerala , India

Keywords:

Psychological Distress, Quality of Life

Abstract

Background

The psychosocial impact of cancer remains unexplored despite its profound influence on patient outcomes. Advances in early detection and treatment have transformed cancer into a chronic, life-threatening condition, increasing the psychosocial burden on patients. Prolonged survival is often accompanied by uncertainty, treatment - related side effects, financial strain, and disruption of social and family roles. Psychosocial distress can impair quality of life (QoL), lower symptom tolerance, reduce treatment adherence and increase health care utilisation. It may adversely affect clinical outcomes, including disease progression and survival through mechanisms such as immune dysregulation. Despite its importance, distress remains under recognised due to stigma and limited access to supportive care, particularly in resource limited settings. The National Comprehensive Cancer Network (NCCN) recognises distress as the “sixth vital sign” and recommends its routine assessment across the cancer trajectory. Understanding psychosocial distress and its impact on QoL is essential for holistic patient centered care. QoL in cancer patients, is a multidimensional concept encompassing global health, functional status and symptom burden.

Objectives

To determine the prevalence of psychosocial distress among cancer patients, assess its association with QoL, and identify sociodemographic and disease related factors associated with distress.

Methods

A cross-sectional study was conducted among 113 adult cancer patients at a tertiary care center. Data were collected using a pretested, interviewer administered questionnaire capturing sociodemographic and disease related factors. Psychosocial distress was assessed using NCCN Distress Thermometer and QoL using the EORTC QLQ-C30 questionnaire. Statistical analysis included chi-square tests, logistic regression, and Pearson correlation, with p<0.05 considered significant.

Results

Clinically significant distress(score≥4) was observed in 63.7% of patients (mean score 4.74 ± 2.91). Pain and impaired physical functioning were the strongest physical correlates. Emotional factors, particularly fear, showed the strongest association, along with sadness, anger and feelings of worthlessness. Social, practical and spiritual concerns were also significant.

Advanced cancer stage(p<0.001) and treatment modality(p=0.011) were strongly associated with distress with higher prevalence among patients receiving chemotherapy and surgery. Symptom severity showed strong association; all patients with moderate to severe symptoms reported clinically significant distress(p=0.003). Although higher distress was observed among females, younger patients, unemployed individuals, those separated or widowed, sole bread winners, rural residents, those with longer disease duration, those receiving active or palliative treatment and certain cancer types, these associations were not statistically significant.

QoL was significantly lower among distressed patients(p<0.001) and showed a moderate negative correlation with distress (r= -0.481). Nearly half (46.9%) had severe QoL impairment. Functional domains were significantly associated with distress(p<0.01) and global health status strongly correlated with QoL(r=0.881)

Conclusion

Psychosocial distress is highly prevalent and significantly affects QoL in cancer patients. It is closely associated with symptom burden, especially pain and functional impairment, as well as emotional, social, and practical challenges. Distress is inversely related to QoL and is higher in advanced disease and certain treatments. Integrating psychosocial care into oncology practice and addressing stigma, limited awareness and inadequate resources through scalable, cost-effective models is essential for equitable, culturally sensitive care and improved outcomes.

References

1. Baye AA, Bogale SK, Delie AT, Melak Fekadie M, Wondyifraw HG, Tigabu ME, Kebede M. Psychosocial distress and associated factors among adult cancer patients at oncology: a case of Ethiopia. Front Oncol. 2023 Dec 21;13:1238002. doi: 10.3389/fonc.2023.1238002. PMID: 38192622; PMCID: PMC10772143.

2. Klein G, Jodocy D. Symptoms and symptom management in survivorship patients. In: Survivorship Care for Cancer Patients: A Clinician’s Handbook. Switzerland: Springer (2021). p. 145–202.

3. Lavanya ML, Mukesh S, Maruthavanan S. Distress in cancer patients and their compliance to treatment: A prospective study. Indian J Cancer. 2025 Apr 1;62(2):209-212. doi: 10.4103/ijc.ijc_1024_22. Epub 2025 Aug 8. PMID: 40788734.

4. Lewis S, Pandey S, Salins N, Deodhar J, Patil V, Gupta T, et al. Distress screening in head and neck cancer patients planned for cancer‑directed radiotherapy. Laryngoscope 2021;131:2023‑9.

5. Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra‑short methods of detecting cancer‑related mood disorders. J Clin Oncol 2007;25:4670‑81.

6. Firdousa J, Singh M, Nisar S. Perceived stress in cancer patients: An integrative review. Indian J Psychiatr Nurs 2021;18:112‑24

7. El-Aziz A, Khallaf S, Abozaid W, Elgohary G, El-Fattah A, Alhawari M, et al. Is it the time to implement the routine use of distress thermometer among Egyptian patients with newly diagnosed cancer? BMC Cancer (2020) 20(1):1–8. doi: 10.1186/ s12885-020-07451-7 53.

8. Carlson LE, Zelinski EL, Toivonen KI, Sundstrom L, Jobin CT, Damaskos P, et al. Prevalence of psychosocial distress in cancer patients across 55 North American cancer centers. J psychosocial Oncol (2019) 37(1):5–21. doi: 10.1080/ 07347332.2018.1521490

9. Meggiolaro E, De Padova S, Ruffilli F, Bertelli T, Bragagni M, Prati S, et al. From distress screening to uptake: an Italian multicenter study of cancer patients. Cancers (2021) 13(15):3761. doi: 10.3390/cancers13153761

10. Alsughayer LY, Altamimi LA, Alsaleh FS, Alsaghan L, Alfurayh I, Abdel-Aziz NM, et al. Prevalence and determinants of distress among oncology patients at a tertiary care medical city in Riyadh, Saudi Arabia. Saudi Med J (2021) 42(7):761. doi: 10.15537/smj.2021.42.7.20210121

11. Jiang C, Deng L, Karr MA, Wen Y, Wang Q, Perimbeti S, et al. Chronic comorbid conditions among adult cancer survivors in the United States: Results from the National Health Interview Survey, 2002-2018. Cancer (2022) 128(4):828–38. doi: 10.1002/cncr.33981

12. Flanagan MW, Goltz HH, Henson JW, Smith ML. Associations of practical, emotional, and physical problems with psychosocial distress among cancer patients. J Psychosocial Oncol (2022) 40(1):98–114. doi: 10.1080/07347332.2021.1899353

13. Ebob-Anya B-A, Bassah N. Psychosocial distress and the quality of life of cancer patients in two health facilities in Cameroon. BMC Palliative Care (2022) 21(1):96. doi: 10.1186/s12904-022-00981-w

14. Kinoti FJ. Psychosocial Distress among Patients with Cancer at Machakos Palliative Care Unit. technology digital repository center: Jomo Keyatta University of agriculture and technology digital repository center (2021).

15. Duan Y, Wang L, Sun Q, Liu X, Ding S, Cheng Q, et al. Prevalence and determinants of psychological distress in adolescent and young adult patients with cancer: a multicenter survey. Asia-Pacific J Oncol Nursing (2021) 8(3):314–21. doi: 10.4103/2347-5625.311005

16. Balasubramanian S, Abraham J, Sobhith VK, Malodan R. Pattern of distress among cancer patients assessed during new patient counseling: A cross-sectional study. Indian J Cancer. 2024 Oct 1;61(4):818-822. doi: 10.4103/ijc.ijc_797_21. Epub 2025 Feb 17. PMID: 39960713.

17. Dessai SB, Chakraborty S, Sajeev Kumar PB, Babu S, Muttath G,

Nair C, et al. Pilot study of single‑day distress screening with the

NCCN distress thermometer to evaluate the feasibility of routine

distress screening in tertiary cancer center in rural India: Feasibility

of distress screening in a rural based hospital. Psychooncology

2015;24:832‑4.

18. Koyama A, Matsuoka H, Ohtake Y, Makimura C, Sakai K, Sakamoto R, et al. Gender differences in cancer-related distress in Japan: a retrospective observation study. BioPsychoSocial Med (2016) 10(1):1–8. doi: 10.1186/s13030-016-0062-8

19. Geue K, Brähler E, Faller H, Härter M, Schulz H, Weis J, et al. Prevalence of mental disorders and psychosocial distress in German adolescent and young adult cancer patients (AYA). Psycho-Oncology (2018) 27(7):1802–9. doi: 10.1002/pon.4730

20. Rao W-W, Yang M-J, Cao B-N, You Y-Y, Zhang Y-Y, Liu Y-Y, et al. Psychological distress in cancer patients in a large Chinese cross-sectional study. J Affect Disord (2019) 245:950–6. doi: 10.1016/j.jad.2018.11.089

21. Carlson LE, Zelinski EL, Toivonen KI, Sundstrom L, Jobin CT, Damaskos P, et al. Prevalence of psychosocial distress in cancer patients across 55 North American cancer centers. J Psychosoc Oncol 2019;37:5‑21.

22. Almigbal TH, Almutairi KM, Fu JB, Vinluan JM, Alhelih E, Alonazi WB, Batais MA, Alodhayani AA, Mubaraki MA. Assessment of psychological distress among cancer patients undergoing radiotherapy in Saudi Arabia. Psychol Res Behav Manag. 2019 Aug 20;12:691-700. doi: 10.2147/PRBM.S209896. PMID: 31693712; PMCID: PMC6708396.

23. Eicher M, Matzka M, Dubey C, White K. Resilience in adult cancer care: an integrative literature review. Oncol Nurs Forum. 2015;42(1): E3–16. doi:10.1188/15

24. Stiegelis HE, Ranchor AV, Sanderman R. Psychological functioning in cancer patients treated with radiotherapy. Patient Educ Couns. 2004;52(2):131–141. doi:10.1016/S0738-3991(03)00021-1

25. Alwhaibi M, Sambamoorthi U, Madhavan S, Bias T, Kelly K, Walkup J. Cancer type and risk of newly diagnosed depression among elderly medicare beneficiaries with incident breast, colorectal, and prostate cancers. J Natl Compr Canc Netw. 2017;15(1):46–55. doi:10.6004/jnccn.2017.0006

26. Bou Khalil R. "Emotional Chemobrain": A new concept for chemotherapy adverse drug effect? L'Encephale (2021) 47(6):613–5. doi: 10.1016/j.encep.2020.08.005

27. Bergerot C, Jacobsen P, Rosa W et al. Global unmet psychosocial needs in cancer care: health policy eClinicalMedicine, 2024; 78

28. Mitchell, A.J. ∙ Chan, M. ∙ Bhatti, H. ∙ et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies Lancet Oncol. 2011; 12(2):160-174

29. Martinez-Calderon, J. ∙ García-Muñoz, C. ∙ Heredia-Rizo, A.M. ∙ et al. The prevalence of anxiety and depression in cancer around the world: an overview of systematic reviews evaluating 128 meta-analyses J Affect Disord. 2024; 351:701-719

30. Goerling, U. ∙ Hinz, A. ∙ Koch-Gromus, U. ∙ et al. Prevalence and severity of anxiety in cancer patients: results from a multi-center cohort study in Germany J Cancer Res Clin Oncol. 2023; 149(9):6371-6379

31. Omari M, Amaadour L, Zarrouq B, et al. Evaluation of psychological distress is essential for patients with locally advanced breast cancer prior to neoadjuvant chemotherapy: baseline findings from cohort study. BMC Womens Health. 2023;23(1):445. 22

32. Abu-Odah H, Molassiotis A, Zhao IY, Su JJ, Allsop MJ. Psychological distress and associated factors among Palestinian advanced cancer patients: a cross-sectional study. Front Psychol. 2022;13: 1061327. 23

33. Negussie F, Giru BW, Yusuf NT, Gela D. Psychological distress and associated factors among cancer patients in public hospitals, Addis Ababa, Ethiopia: a cross-sectional study. BMC Psychol. 2023;11(1):41. 24

34. Alsughayer LY, Altamimi LA, Alsaleh FS, et al. Prevalence and determinants of distress among oncology patients at a tertiary care medical city in Riyadh, Saudi Arabia. Saudi Med J. 2021;42(7):761– 768. 25

35. Wang YH, Li JQ, Shi JF, et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and metaanalysis of cohort studies. Mol Psychiatry. 2020;25(7):1487–1499.

36. Chang WH, Lai AG. Cumulative burden of psychiatric disorders and self-harm across 26 adult cancers. Nat Med. 2022;28(4):860– 870.

37. Heinrich M, Hofmann L, Baurecht H, et al. Suicide risk and mortality among patients with cancer. Nat Med. 2022;28(4):852– 859.

38. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–263.

39. Miroševič Š, Prins JB, Selič P, Zaletel Kragelj L, Klemenc Ketiš Z. Prevalence and factors associated with unmet needs in post‐treatment cancer survivors: a systematic review. European journal of cancer care. 2019 May;28(3):e13060..

40. Bellas O, Kemp E, Edney L, Oster C, Roseleur J. The impacts of unmet supportive care needs of cancer survivors in Australia: a qualitative systematic review. Eur J Cancer Care. 2022;31(6):e13726.

41. Fan R, Wang L, Bu X, Wang W, Zhu J. Unmet supportive care needs of breast cancer survivors: a systematic scoping review. BMC Cancer. 2023;23(1):58

42. Riba MB, Donovan KA, Ahmed K, et al. NCCN Guidelines® insights: distress management, version 2.2023. J Natl Compr Canc Netw. 2023;21(5):450–457.

43. Subbiah IM, Charone MM, Roszik J, et al. Association of edmonton symptom assessment system global distress score with overall survival in patients with advanced cancer. JAMA Netw Open. 2021;4(7):e2117295.

44. Bergerot CD, Bergerot PG, Molina LNM, et al. Impact of a biopsychosocial screening program on clinical and hospital-based outcomes in cancer. JCO Oncol Pract. 2023;19(6):e822–e828

45. Chang WH, Lai AG. Cumulative burden of psychiatric disorders and self-harm across 26 adult cancers. Nat Med. 2022;28(4):860– 870.

46. Heinrich M, Hofmann L, Baurecht H, et al. Suicide risk and mortality among patients with cancer. Nat Med. 2022;28(4):852– 859

47. Abdelhadi O. The impact of psychological distress on quality of care and access to mental health services in cancer survivors. Front Health Serv. 2023;3:1111677.

48. Kang D, Kim N, Kim H, et al. Emulating trial to evaluate the effectiveness of routine supportive care on mortality among cancer patients experiencing distress at the time of diagnosis. J Affect Disord. 2024;354:519–525.

49. Weis J. Psychosocial Care for Cancer Patients. Breast Care (Basel). 2015 Apr;10(2):84-6. doi: 10.1159/000381969. PMID: 26195935; PMCID: PMC4463789.

50. Schmid-Büchi S, Halfens RJG, Dassen T, van den Borne B. Psychosocial problems and needs of posttreatment patients with breast cancer and their relatives. Eur J Oncol Nurs. 2011;15:260–266. doi: 10.1016/j.ejon.2009.11.001. [DOI] [PubMed] [Google Scholar]

Downloads

Published

2026-08-18

How to Cite

PARVATHI SUDHA HARI, Ciniraj Raveendran, Sudha Padmam, & Libu G K. (2026). Assessment of Psychosocial Distress in Cancer Patients and its Association with Quality of Life -A Cross-Sectional Study. International Journal of Medical Students. Retrieved from https://ijms.pitt.edu/IJMS/article/view/4556

Issue

Section

Abstracts of the WCMSR

Categories